Page 8 - Nucleus Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Murdoch Childrens Research Institute Researchers have successfully developed a new Strep A human challenge model, paving the way to test vaccines against the common deadly bacteria that causes sore throats, scarlet fever and skin sores. The collaborative research effort, led by the Murdoch Children’s Research Institute (MCRI) and published in The Lancet Microbe, found the model, which deliberately infected healthy adult volunteers with the bacteria in a controlled environment, was safe and would now be used to trial Strep A candidate vaccines. Strep A infections affect about 750 million peo...

Health by Tiffany Bakker Premium Content   We're on a first-name basis with the AstraZeneca vaccine and we know all about Pfizer and, if you have family overseas, chances are you've heard about Moderna and Johnson & Johnson. But how many new COVID-19 vaccines are in development, when will they be ready for use and just how will we take them?   HOW MANY COVID VACCINES ARE IN DEVELOPMENT? According to the World Health Organisation, there are currently 277 coronavirus vaccines in development globally, of which 93 have entered the human testing phase. ...

Health by Tiffany Bakker Premium Content   We're on a first-name basis with the AstraZeneca vaccine and we know all about Pfizer and, if you have family overseas, chances are you've heard about Moderna and Johnson & Johnson. But how many new COVID-19 vaccines are in development, when will they be ready for use and just how will we take them?   HOW MANY COVID VACCINES ARE IN DEVELOPMENT? According to the World Health Organisation, there are currently 277 coronavirus vaccines in development globally, of which 93 have entered the human testing phase. ...

Lazard, Allens test interest in Aussie lab services play 360Biolabs Save Share Australian laboratory services provider 360Biolabs is seeking to capitalise on red-hot demand for biotech research testing companies and their service providers. 360Biolabs provides laboratory services to clinical research organisations, helping to test and develop the next wave of therapeutics, vaccinations and diagnostic tools.  Stuart Layt Street Talk can reveal 360Biolabs, which is based in Melbourne and makes $20 million EBITDA a year, has called in bankers at Lazard to pitch the business to potential buyer...

Last modified on Thu 22 Apr 2021 23.01 EDT Australia is set to host the first human clinical trial of a genetically modified adenovirus vaccine for Covid-19 delivered via nasal spray. Avance Clinical, an Australian contract research organisation, has applied to the office of the gene technology regulator for permission to conduct the phase 1 clinical trial on behalf US company Tetherex Pharmaceuticals Corporation. The trial from June to September proposes using genetic modification to prevent the virus multiplying and insert a gene encoding the Sars-Cov-2 spike protein to help people produce ...